Moderna vaccine 96 percent effective in 12-17 year-olds, study shows
Moderna said Thursday its COVID-19 vaccine is 96 percent effective among youths aged 12 to 17, according to the results of its first clinical trials.
by ·
Moderna said Thursday its COVID-19 vaccine is 96 percent effective among youths aged 12 to 17, according to the results of its first clinical trials.
by · Published April 26, 2021
by · Published May 7, 2021
by · Published April 26, 2021